flow trial semaglutide kidney outcomes hazard ratio 0.76

flow trial semaglutide kidney outcomes hazard ratio 0.76 Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine Effects of Semaglutide on Heart

Name: flow trial semaglutide kidney outcomes hazard ratio 0.76 Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future | Endocrine Effects of Semaglutide on Heart
Brand: www.aliseon.com
SKU: 10145833645
Price: 27.01 USD
Availability: InStock
Rating: 4.1647 (7 reviews)

SKU: 10145833645

4.2

EUR27.01 EUR73.01

Pay in 4 interest-free payments of $6.75 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 7 - Sep 12

Description

It includes consultations with a clinician and a medically appropriate treatment program, which can include medications

Carlos, C

Ueda and colleagues ran a nationwide Swedish register-based cohort (20132024), comparing initiators of GLP-1 receptor agonists (~107,500) against initiators of SGLT-2 inhibitors (~186,000)